REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/10/2026
Back to search
Official data from USPTO
VALIDUS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
01/11/2026
Trademark type
Combined
Nice classes
5
Filing date
11/10/2015
Registration date
01/10/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2023
Last transaction
01/11/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
02/06/2007
First use in commerce
02/06/2007
Drawing code
3
Owner type
16
Owner location
PARSIPPANY, NJ
Examiner
PAQUIN,SAMUEL ROBERT
Law office
L10
Current location
TMEG LAW OFFICE 101
Mark description
The mark consists of the stylized wording "VALIDUS PHARMACEUTICALS" with an arch consisting of seven squares from the letter "V" to the letter "I" in "VALIDUS".
Holders and representatives
Holders
VALIDUS PHARMACEUTICALS LLC
VALIDUS PHARMACEUTICALS LLC
Representatives
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
HOUSE MARK FOR PHARMACEUTICAL FORMULATIONS FOR HUMAN USE
Publications
History of USPTO decisions and trademark events.
38 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/30/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2023
ES8R
TEAS SECTION 8 RECEIVED
01/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/10/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2016
PUBO
PUBLISHED FOR OPPOSITION
10/25/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2016
ALIE
ASSIGNED TO LIE
09/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/17/2016
GNRT
NON-FINAL ACTION E-MAILED
08/17/2016
CNRT
NON-FINAL ACTION WRITTEN
08/17/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/03/2016
GNRT
NON-FINAL ACTION E-MAILED
03/03/2016
CNRT
NON-FINAL ACTION WRITTEN
03/03/2016
DOCK
ASSIGNED TO EXAMINER
03/03/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/14/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2015
NWAP
NEW APPLICATION ENTERED
11/13/2015
Continuous trademark protection
Get notified about every new filing that threatens VALIDUS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.